Air pollution's effects on fat metabolism, heart health, and Alzheimer's risk

Dissecting the Role of Arachidonic Acid Metabolic Pathways Involved in Resolution Versus Progression of PM-Induced Cardiometabolic Toxicity

NIH-funded research University of California Los Angeles · NIH-11300060

This project looks at whether air pollution causes harmful changes in fat and heart metabolism that can worsen Alzheimer's-related brain damage and whether shifting arachidonic acid pathways can change those outcomes.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of California Los Angeles NIH-funded
Lab location1 site (Los Angeles, United States)
Project IDNIH-11300060 on NIH RePORTER

What this research studies

From a patient's perspective, this work uses a mouse model that develops high blood fats and atherosclerosis and exposes those mice to ultrafine air pollution and diesel particles, then examines liver, blood, and brain tissue for inflammation and lipid damage. The team focuses on biochemical pathways that make and resolve inflammatory molecules from arachidonic acid to see which patterns link pollution exposure to worsening or improving brain changes associated with Alzheimer's. They compare animals on a high-fat diet with and without pollution exposure and analyze brain tissue alongside liver and blood lipids. The goal is to find molecular signals that could be targeted to lower pollution-related Alzheimer's risk.

Who could benefit from this research

Good fit: People with high cardiovascular or metabolic risk, or those living in areas with heavy air pollution, would be most relevant to follow or participate in future related human studies.

Not a fit: Patients without cardiovascular or metabolic risk factors and with minimal exposure to air pollution are less likely to directly benefit from this specific research.

Why it matters

Potential benefit: If successful, this work could reveal biological pathways that connect air pollution and cardiometabolic changes to Alzheimer's risk, pointing to new prevention strategies or drug targets.

How similar studies have performed: Previous animal studies have shown that ultrafine particles and diesel exhaust cause systemic inflammation and lipid damage, but linking arachidonic acid metabolic pathways specifically to Alzheimer's progression is relatively novel.

Where this research is happening

Los Angeles, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-10 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.